70 - Intermediate-Dose Cytarabine as Postinduction AML Therapy

from TMO EPM / Hemato H9J Hosted by TMO EPM / Hemato H9J

Discussão do artigo: "Intermediate-Dose Cytarabine as Postinduction AML Therapy" de Hunault M NEJM evidence 2025 Apresentado por: Dr. Guilherme Rodrigues Discussão por: Dra. Gabrielle Ritter, Dr. Lucas Salviano, Dr. Rafael Faust, Dr. Pedro Moraes e Dr. Vinicius Molla.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

70 - Intermediate-Dose Cytarabine as Postinduction AML Therapy

0:00 32:40

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Hematology Medical Conversation COR2ED Medical Education Join hematology medical experts as they discuss their approaches to hemato-oncology and hemostasis. The conversations explore scientific data, treatment landscapes, and patient experiences of various bleeding disorders and blood cancers incl. lymphoma, myeloma, hemophilia, von Willebrand disease and thrombosis. This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com

Frequently asked questions

How long is this episode of TMO EPM / Hemato H9J?

This episode is 32 minutes long.

When was this TMO EPM / Hemato H9J episode published?

This episode was published on April 8, 2026.

Can I download this TMO EPM / Hemato H9J episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.